Nuvation Bio Inc. NUVB
Set alert
4.59 USD -0.17 -3.57%
At close
4.59 0.00 0.00%
Pre-market · Nov 3, 4:00 AM ET
4.59 Day range 4.85
3.92 52-week range 9.75
- YTD
- -48.77%
- 1 year
- -12.07%
- Open
- 4.80
- Prev close
- 4.76
- Mkt cap
- 1.61B
- Vol
- 3.72M
- Avg vol
- 5.35M
- EPS
- -0.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.59
- High
- 4.85
- Forward P/E
- -306.67
- Beta
- 1.73
- Short ratio
- 11.57
- Inst. own
- 67.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 5.63
- 200-d avg
- 5.40
- 1y target
- 13.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 13.00 +183.2% upside
Now 4.59
- Target (low)
- 7.00
- Target (mean)
- 13.00
- Target (high)
- 21.00
Ratings (0m) 13 12 buy · 1 hold · 0 sell
- Strong buy3
- Buy9
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.10333 | -0.13 – -0.09 | -0.1395 | +25.9% | 34.42M | +162.4% | 3 |
| Next quarter | -0.09 | -0.09 – -0.09 | -0.086 | -4.7% | 45.26M | +8.1% | 2 |
| Current year | -0.29 | -0.29 – -0.29 | -0.494 | +41.3% | 194.60M | +209.4% | 2 |
| Next year | -0.015 | -0.08 – 0.05 | -0.29 | +94.8% | 275.55M | +41.6% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 2026 | Citigroup | Initiated | — | Buy |
| Sep 16, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Sep 16, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 21, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Aug 18, 2026 | JP Morgan | Initiated | — | Overweight |
| Aug 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 27, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 23, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 5, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| May 5, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| May 5, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 16, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Apr 2, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 27, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 3, 2026 | UBS | Maintained | Neutral | Neutral |
| Mar 3, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 10, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jan 21, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 7, 2026 | UBS | Initiated | — | Neutral |
| Dec 11, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 1, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 24, 2025 | Truist Securities | Initiated | — | Buy |
| Nov 20, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 19, 2025 | B. Riley Securities | Initiated | — | Buy |
| Nov 4, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 4, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Oct 13, 2025 | Wedbush | Reiterated | Outperform | Outperform |